Sun Pharma Share Price Target From 2024 to 2035 : Sun Pharmaceutical Industries Limited, widely known as Sun Pharma, is one of India’s most prominent pharmaceutical companies and a leading global player in the generic drug industry. Since its inception in 1983, Sun Pharma has witnessed rapid growth through strategic acquisitions, a strong product pipeline, and aggressive global expansion. This article presents a comprehensive analysis of Sun Pharma stock price targets from 2024 to 2030, providing valuable insights for both market enthusiasts and investors.
Company Overview of Sun Pharma
Background of Sun Pharma
Sun Pharma began its journey by manufacturing and marketing products in specialty areas such as psychiatry, gastroenterology and cardiology. Over the years, the company has diversified its product portfolio and expanded its presence in various therapeutic areas including oncology, dermatology and neurology. The acquisition of Ranbaxy Laboratories in 2014 proved to be a significant milestone, furthering Sun Pharma’s growth strategy, which has been a combination of organic expansion and strategic acquisitions.
Market Presence and Financial Metrics
- Market Cap: ₹4.17 Lakh Crore
- Open: ₹1735.00
- High: ₹1748.65
- Low: ₹1728.35
- P/E Ratio: 40.14
- Dividend Yield: 0.78%
- 52-Week High: ₹1758.00
- 52-Week Low: ₹1068.3
Global Presence of Sun Pharma
Sun Pharma operates in over 100 countries and has a strong presence in key markets such as the US, Europe and emerging economies. Its global presence is supported by over 40 manufacturing facilities and a strong pipeline of generic and specialty products. The company’s extensive R&D capabilities further strengthen its position in the global pharmaceutical landscape.
Sun Pharma Share Price Targets (2024-2035)
| Year | Share Price Target (₹) |
| 2024 | 1810.30 |
| 2025 | 1926.00 |
| 2026 | 2114.45 |
| 2027 | 2295.00 |
| 2028 | 2476.00 |
| 2029 | 2796.00 |
| 2030 | 2898.00 |
| 2031 | 3000.00 |
| 2032 | 3104.00 |
| 2033 | 3202.00 |
| 2034 | 3300.00 |
| 2035 | 3398.00 |
SUN PHARMA RECENT SHARE PRICE GRAPH
READ MORE:
Akums Drugs Share Price: Historical Data and Performance Review
Tata Power Share Price Prediction for 2023, 2024, 2025, 2030, and 2040
LIC Share Price Target 2023, 2024, 2025, 2027, 2030
SUN PHARMA SHARE PRICE TOMORROW
The Sun Pharma Share Price for Tomorrow is fully based on the Market insights and the sun pharma company valuations
Analysis of Sun Pharma’s Share Price Projections
SUNPHARMA share price target 2024
In the year 2024, SUNPHARMA’s growth momentum is expected to continue despite possible market consolidation in the initial months. The lowest share price target for the year is ₹1387.6, while the highest expected price target by the end of the year is ₹1810.30, The growth is likely driven by strong market sentiment and technical indicators.
Monthly Price Projections for 2024
- April: ₹1387.6
- May: ₹1419.64
- June: ₹1451.68
- July: ₹1483.71
- August: ₹1515.75
- September: ₹1547.79
- October: ₹1579.83
- November: ₹1711.86
- December: ₹1810.3
In 2024, Sun Pharma is expected to focus on strengthening its market position and implementing strategic initiatives to drive growth. Key drivers include the launch of new products, expansion into new markets, and continued integration of acquired companies. The company’s robust pipeline and strong R&D capabilities will be key in driving revenue growth and improving margins.
SUNPHARMA Share Price Target 2025
The bullish trend for SUNPHARMA is expected to continue till 2025, with an estimated opening price of ₹1677 in January. The stock may see some volatility, but if market conditions remain favorable, it can reach ₹1926 by December 2025.
Monthly Price Projections for 2025:
- January: ₹1677
- February: ₹1711
- March: ₹1745
- April: ₹1687
- May: ₹1631
- June: ₹1577
- July: ₹1640
- August: ₹1706
- September: ₹1774
- October: ₹1809
- November: ₹1895
- December: ₹1926
By 2025, Sun Pharma aims to leverage its extensive product pipeline to introduce new therapies and expand its presence in key therapeutic areas. The company’s strategic focus on high-growth markets such as the U.S. and Europe will contribute to revenue growth. Additionally, efforts to optimize manufacturing efficiencies and streamline operations will enhance profitability.
SUNPHARMA Share Price Target 2026
In 2026, SUNPHARMA share price is expected to witness a strong surge, with a starting price of ₹ 1927. The stock may face some challenges in the middle of the year, possibly dropping to ₹ 1904, but it is projected to recover and close the year at ₹ 2114.
Monthly Price Projections for 2026:
- January: ₹1927
- February: ₹1958
- March: ₹1997
- April: ₹1930
- May: ₹1866
- June: ₹1904
- July: ₹1876
- August: ₹1951
- September: ₹2029
- October: ₹2070
- November: ₹2111
- December: ₹2114
Innovation and strategic partnerships will be the focal points for Sun Pharma in 2026. The company’s investments in R&D are expected to lead to new product launches, especially in the specialty and complex generics segments. Collaborations with global pharmaceutical companies and research institutes will enhance Sun Pharma’s capabilities and market reach, boosting top-line growth and supporting higher valuations.
SUNPHARMA Share Price Target 2027
Using Fibonacci projections, the SUNPHARMA share price is expected to fluctuate between ₹2156 and ₹2295 for 2027. Despite the anticipated volatility, the overall trend for the year remains positive.
Monthly Price Projections for 2027:
- January: ₹2156
- February: ₹2240
- March: ₹2285
- April: ₹2209
- May: ₹2135
- June: ₹2064
- July: ₹2147
- August: ₹2233
- September: ₹2242
- October: ₹2268
- November: ₹2275
- December: ₹2295
By 2027, Sun Pharma is projected to achieve operational excellence and strengthen its market leadership. The company’s focus on optimizing supply chain management, improving manufacturing processes, and reducing costs will enhance operational efficiencies. Sun Pharma’s leadership in key therapeutic areas and its ability to deliver high-quality, cost-effective medicines will strengthen its market position and drive stock price growth.
SUNPHARMA Share Price Target 2028
In 2028, SUNPHARMA is expected to continue its growth, with an initial price target of ₹2312. The stock may experience some corrections mid-year but is likely to end the year at ₹2476.
Monthly Price Projections for 2028:
- January: ₹2212
- February: ₹2262
- March: ₹2273
- April: ₹2286
- May: ₹2292
- June: ₹2341
- July: ₹2355
- August: ₹2373
- September: ₹2385
- October: ₹2408
- November: ₹2462
- December: ₹2476
Emerging markets will present significant growth opportunities for Sun Pharma in 2028. The company’s strategic initiative to enter high-growth regions such as Asia-Pacific, Latin America and Africa will diversify its revenue base and reduce dependence on mature markets. Sun Pharma’s localized strategies, tailored product offerings and strategic partnerships will drive market expansion and revenue growth.
SUNPHARMA Share Price Target 2029
This uptrend is expected to continue in 2029, and SUNPHARMA share price could reach ₹2796 by the end of the year. This growth is expected to be driven by positive market trends and strong performance in the pharmaceutical sector.
Monthly Price Projections for 2029:
- January: ₹2673
- February: ₹2680
- March: ₹2683
- April: ₹2659
- May: ₹2687
- June: ₹2700
- July: ₹2675
- August: ₹2680
- September: ₹2695
- October: ₹2698
- November: ₹2760
- December: ₹2796
Technological advancements and sustainable growth will be the key drivers for Sun Pharma in 2029. The company’s investments in digital technologies, automation, and data analytics will increase operational efficiency and improve decision making. Sun Pharma’s commitment to sustainability and corporate social responsibility will strengthen its brand reputation and attract socially conscious investors.
SUNPHARMA Share Price Target 2030
By 2030, SUNPHARMA’s share price is expected to rise significantly, possibly reaching ₹2898 by December. This forecast takes into account both the cumulative effect of market dynamics and the company’s consistent performance over the past few years.
Monthly Price Projections for 2030:
- January: ₹2797
- February: ₹2879
- March: ₹2877
- April: ₹2888
- May: ₹2892
- June: ₹2765
- July: ₹2789
- August: ₹2798
- September: ₹2800
- October: ₹2807
- November: ₹2818
- December: ₹2898
By 2030, Sun Pharma expects to consolidate its leadership in the specialty pharmaceuticals segment. The company’s focus is on specific therapeutic areas, complex generics and biologics, which will differentiate it from competitors and support premium pricing. Sun Pharma’s strong pipeline, robust intellectual property portfolio and strategic acquisitions will drive continued growth and higher valuations.
SUNPHARMA Share Price Target 2031
2031: Consolidation and Strategic Initiatives
- Low Target: ₹2945
- High Target: ₹3000.29
SUNPHARMA Share Price Target 2032
2032: Product Pipeline and Market Expansion
- Low Target: ₹3039.99
- High Target: ₹3104.09
SUNPHARMA Share Price Target 2033
2033: Innovation and Strategic Partnerships
- Low Target: ₹3178
- High Target: ₹3202.29
SUNPHARMA Share Price Target 2034
2034: Operational Excellence and Market Leadership
- Low Target: ₹3279
- High Target: ₹3300.29
SUNPHARMA Share Price Target 2035
2035: Expansion into Emerging Market
- Low Target: ₹3345
- High Target: ₹3398.29
Key Takeaways for SUNPHARMA’s Forecasted Growth (2024-2035)
- 2024: SUNPHARMA is expected to experience significant growth, with targets ranging from ₹1387.6 to ₹1810.3
- 2025: The bullish trend may continue, potentially taking the stock to ₹1926 by year-end.
- 2026: Despite potential mid-year challenges, the share price could reach ₹2114.
- 2027: Anticipated market volatility might cause fluctuations, but an overall upward trajectory is expected.
- 2028-2029: Strong and steady growth is likely, with SUNPHARMA setting new records.
- 2030: The stock could achieve a substantial year-end target of ₹2898, driven by long-term positive trends.
- 2031: At the end of 2031 target hits ₹3000.29
- 2032: At the end of 2032 target hits ₹3104.09
- 2033: At the end of 2032 target hits ₹3202.29
- 2034: At the end of 2032 target hits ₹3300.29
- 2035: At the end of 2032 target hits ₹3398.29
Factors Influencing Sun Pharma’s Share Price
Several factors will influence Sun Pharma’s share price over the coming years:
- Product Pipeline: Successful launch and commercialization of new products will drive revenue growth and market share expansion.
- Regulatory Environment: Favorable regulatory approvals and compliance with international standards will support market entry and product launches.
- Market Expansion: Penetration into new markets and expansion of the company’s footprint in high-growth regions will diversify revenue streams.
- R&D Investments: Continued investment in R&D will drive innovation, enhance the product pipeline, and support long-term growth.
- Operational Efficiency: Optimization of manufacturing processes, supply chain management, and cost control measures will enhance profitability.
- Strategic Partnerships: Collaborations with global pharmaceutical companies, research institutions, and technology firms will enhance capabilities and market reach.
- Economic Conditions: Macro-economic factors such as economic growth, inflation, and currency fluctuations will impact consumer purchasing power and investment decisions.
Conclusion
Sun Pharma’s share price is poised for significant growth from 2024 to 2030.
Disclaimer
Stock forecasts and targets are educational tools and may not be reliable for making financial decisions. This article is not a recommendation to buy or sell any stock. Always consult a professional before making investment decisions.